As of 2024-12-12, the Intrinsic Value of 89Bio Inc (ETNB) is
-12.29 USD. This 89Bio valuation is based on the model Peter Lynch Fair Value.
With the current market price of 8.04 USD, the upside of 89Bio Inc is
-252.83%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-12.29 USD
Intrinsic Value
89Bio Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-12.29 - -12.29 |
-12.29 |
-252.83% |
| P/E |
(43.74) - (44.97) |
(36.80) |
-557.7% |
| DDM - Stable |
(19.60) - (68.32) |
(43.96) |
-646.8% |
| DDM - Multi |
(8.97) - (24.76) |
(13.22) |
-264.5% |
89Bio Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
945.34 |
| Beta |
1.38 |
| Outstanding shares (mil) |
117.58 |
| Enterprise Value (mil) |
889.48 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.01% |
| Cost of Debt |
5.00% |
| WACC |
9.88% |